NASDAQ:LNCR - Lincare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lincare logoLincare Holdings Inc. (Lincare) is a provider of oxygen, respiratory and other chronic therapy services to patients in the home. The Company's customers suffer from chronic obstructive pulmonary disease (COPD), such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen, respiratory and other chronic therapy services. As of December 31, 2011, the Company served more than 800,000 customers in 48 states of the United States and Canada through 1,108 operating centers. Lincare primarily provides oxygen, respiratory and other chronic therapy services to patients in the home. It also provides a variety of durable medical equipment (DME) and home infusion therapies in certain geographic markets. During the year ended December 31, 2011, the Company acquired companies that were contracted to provide home oxygen equipment and positive airway pressure devices. In August 2012, Lincare announced that The Linde Group completed its previously announced acquisition of the Company.

Receive LNCR News and Ratings via Email

Sign-up to receive the latest news and ratings for LNCR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:LNCR
CUSIPN/A
Phone+1-813-5307700

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Lincare (NASDAQ:LNCR) Frequently Asked Questions

What is Lincare's stock symbol?

Lincare trades on the NASDAQ under the ticker symbol "LNCR."

Has Lincare been receiving favorable news coverage?

Media headlines about LNCR stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lincare earned a coverage optimism score of 0.20 on Accern's scale. They also assigned headlines about the healthcare company an impact score of 46.66 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Lincare.

How do I buy shares of Lincare?

Shares of LNCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Lincare?

Lincare's mailing address is 19387 US Highway 19 N, CLEARWATER, FL 33764-3102, United States. The healthcare company can be reached via phone at +1-813-5307700.


MarketBeat Community Rating for Lincare (NASDAQ LNCR)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  148
MarketBeat's community ratings are surveys of what our community members think about Lincare and other stocks. Vote "Outperform" if you believe LNCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LNCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: Technical Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel